Skip to main content

Bone health

Latest articles

16-02-2018 | Oncology | News | Article

Denosumab offers alternative to zoledronic acid in multiple myeloma

Phase III study data show that the RANKL-targeting monoclonal antibody denosumab is noninferior to zoledronic acid for the prevention of bone disease in patients with newly diagnosed multiple myeloma.


Lancet Oncol 2018; Advance online publication

22-08-2017 | Prostate cancer | News | Article

Osteoporosis drugs counter deleterious effects of ADT on bone health

Among men receiving androgen deprivation therapy for nonmetastatic prostate cancer, treatment with bisphosphonates and denosumab improves bone mineral density, shows a meta-analysis.


Ann Intern Med 2017; Advance online publication

21-01-2016 | Endocrinology | News | Article

Parathyroid hormone may mediate antihypertensive fracture risk

medwireNews: Parathyroid hormone (PTH) levels may be elevated by use of some antihypertensive agents but reduced by others, analysis of the Multi-Ethnic Study of Atherosclerosis (MESA) suggests. The ...


J Bone Miner Res 2016; Advance online publication

22-08-2013 | Respiratory | Article

Exacerbations key to COPD–osteoporosis connection

Researchers have shown that bone resorption is increased during exacerbations of chronic obstructive pulmonary disease, adding to growing evidence of a strong association between the disease and osteoporosis.


Clin Biochem2013; Advance online publication

02-06-2013 | Metabolism | Article

Primary care physicians boost prostate cancer BMD monitoring

A US study has found that rates of bone mineral density testing in men with prostate cancer receiving androgen deprivation therapy are highest among those whose primary care physician is involved in their care.


J Gen Intern Med 2013; Advance online publication

15-04-2013 | Radiology | Article

Incidental CT could boost osteoporosis detection

Patients undergoing abdominal computed tomography could be assessed for incidental osteoporosis of the lumbar spine, US researchers say.


Ann Intern Med 2013; 158: 588–595

07-03-2013 | Surgery | Article

Femoral canal change detected in women over time

Women experience a gradual expansion in femoral canal diameter with increasing age, which could impact the longevity of total hip replacement, UK researchers report.


Bone Joint J 2013; 95B: 339–342

20-02-2013 | Surgery | Article

Optimal preoperative hallux valgus assessment unclear

Podiatrists lack guidance on the best way to use preoperative radiographs of hallux valgus, research suggests.


J Foot Ankle Surg 2013; Advance online publication

18-02-2013 | Surgery | Article

Oblique split graft technique avoids rhinoplasty warp

A novel graft technique may reduce the risk of costal cartilage graft warping in patients undergoing septorhinoplasty for saddle nose deformity with depleted source, Turkish surgeons say.


JAMA Facial Plast Surg 2013; Advance online publication

17-02-2013 | Sports medicine | Article

Dance-related injuries in young people on the increase

Findings spanning 17 years suggest that dance-related injuries in children and adolescents in the USA have increased by 37% over this time.


J Phys Act Health 2013; 10: 143-150

17-02-2013 | Immunology | Article

Antibody test ‘inappropriate’ without connective tissue symptoms

The positive antinuclear antibody test is often used inappropriately in patients without indications of connective tissue disease, real-world research suggests.


Am J Medicine 2013; Advance online publication

14-02-2013 | Surgery | Article

Opaque procedure pricing barrier to healthcare reforms

US investigators report great difficulty in obtaining price information for total hip arthroplasty from healthcare providers, with many institutions and physicians unable to provide reasonable price estimates.


JAMA Intern Med 2013; Advance online publication

13-02-2013 | Surgery | Article

Foot and ankle assessments fail to capture patient concerns

Commonly used clinical measurements of foot and ankle outcome do not reflect patient concerns, missing the impact of age and gender on how patients define treatment success, US researchers caution.


J Bone Joint SurgAm 2013; 95: 209–214

11-02-2013 | Surgery | Article

Growth factor aids mandible reconstruction

Surgeons have used recombinant human bone morphogenetic protein-2 to successfully restore mandibulectomy defects with few adverse effects.


JAMA Facial Plast Surg 2013; Advance online publication

11-02-2013 | Physical rehabilitation | Article

Piroxicam ultrasound combination optimal for knee osteoarthritis

Phonophoresis of the non steroidal anti-inflammatory drug piroxicam with ultrasound is more effective than ultrasound alone for improving pain and other symptoms of mild-to-moderate knee osteoarthritis, show study findings.


Arch Phys Med Rehabil 2013; 94: 250–255

11-02-2013 | Immunology | Article

UV prevention measures may influence rheumatoid arthritis incidence

Increased ultraviolet-B exposure reduces the risk for rheumatoid arthritis in women, US researchers suggest, but the drive to protect against skin cancer in recent years may have negated this benefit.


Ann Rheum Dis 2013; Advance online publication

03-02-2013 | General practice | Article

Indian medicines ‘promising’ for osteoarthritis care

Ayurvedic medicine may offer osteoarthritis relief, say Indian researchers who found traditional formulations to be equal to conventional drugs for the improvement of pain and knee function.


Rheumatol 2013; Advance online publication

31-01-2013 | Physical rehabilitation | Article

Rehabilitation challenges need for surgical ACL repair

Surgery is not always necessary for acute anterior cruciate ligament injury in young, active patients, research suggests.


BMJ 2013; 346: f232

30-01-2013 | Podiatry | Article

Viscosupplementation may relieve subtalar osteoarthritis

Research suggests that patients with advanced subtalar osteoarthritis may benefit from intra-articular viscosupplementation.


J Foot Ankle Surg 2013; Advance online publication

28-01-2013 | Immunology | Article

Tofacitinib fights rheumatoid arthritis progression

Tofacitinib treats symptoms and prevents structural damage in patients with rheumatoid arthritis who do not respond well to methotrexate, indicate phase III trial findings.


Arthritis Rheum 2013; Advance online publication